Datos del Documento


Título: Clinical trials of controlled-release melatonin in children with sleep–wake cycle disorders
  Enlace: 10.1034/j.1600-079X.2000.290105.x
  Autores: Jan, J.E.; Hamilton, Don; Seward, Nadine; Fast, Diane K.; Freeman, Roger D.; Laudon, Moshe;
  Tipo de documento: Articulo de revista
  Idioma: Inglés
  Resumen:This is the first study to examine effective doses of controlled-release (CR) melatonin in children with chronic sleep–wake cycle disorders. All 42 subjects had severe neurodevelopmental difficulties. Initially, a randomized double-blinded cross-over design was used in 16 children, comparing the effectiveness of fast-release (FR) and CR melatonin. In the remainder of the patients, the CR melatonin was studied on a clinical basis. The effectiveness of treatment was assessed by sleep charts and clinical follow-up. Emphasis was placed on the judgement of the parents, who had guidance from the physicians. The average final CR melatonin dose in the 42 patients was 5.7 mg (2–12 mg). The studies showed that the FR melatonin was most effective when there was only delayed sleep onset, but CR formulations were more useful for sleep maintenance. Children appeared to require higher doses than adults.
  Descriptores: melatonin; children; cronic sleep disorder; neurodevelopmental disorder;
  Soporte: --No definido--
  Ilustraciones:
  Tipo documento: Revista
  Nombre revista: Journal of Pineal Research
  ISSN: 1600-079X
  Periodicidad:
  Volumen: 29
  Número: 1
  Páginas: 34-39
  Año: 2000
Afiliada a WAIMH
World Association
for Infant Mental Health
© ASMI C/ Gorgos nº17-14ª 46021 Valencia · info.asmi.waimh@gmail.com · Tel.: 630 137 817 · Datos legales